Indications: Tardive dyskinesia tardive dyskinesia is a neurological disorder characterized by involuntary movements believed to be caused by dopamine hypersensitivity, and which is associated with the long-term use of antipsychotic drugs that antagonize dopamine receptors
NAC is a popular supplement known for alleviating the side effects of certain medications, breaking down mucus, and supporting respiratory and cardiovascular health
doi: 10.1097/MD.0000000000024191 49 HongY.ShaoA.WangJ.ChenS.WuH.McBrideD
Disclosures: Bridget Keenan: Genentech: Travel, Genentech: Grant/Research Support, Apexigen (now Pyxis Oncology): Grant/Research Support, Regeneron: Consultant, Regeneron: Grant/Research Support, Innovative Cellular Therapeutics: Grant/Research Support, Antengene: Grant/Research Support, AstraZeneca: Grant/Research Support, Partner Therapeutics: Grant/Research Support, Takeda: Grant/Research Support, Bryan Khuong Le: Nothing to Disclose, Quincy Harris: Nothing to Disclose, Jocelin Chen: Nothing to Disclose, Alexander Cheung: Nothing to Disclose, Zenghua Fan: Nothing to Disclose, Frances Lara: Nothing to Disclose, John Gordan: Nothing to Disclose, Paige Bracci: Nothing to Disclose, Spencer Behr: Nothing to Disclose, Lawrence Fong: Nothing to Disclose, Alan Venook: Nothing to Disclose, Edward Kim: Nothing to Disclose, Robin Kelley: Astra Zeneca: Grant/Research Support, Bayer: Grant/Research Support, Bristol Meyer Squibb: Grant/Research Support, Exelixis: Grant/Research Support, Eli Lilly: Grant/Research Support, Genentech/Roche: Grant/Research Support, Genentech/Roche: Grant/Research Support, GSK: Consultant, Kinnate: Consultant, J Pharma Inc.: Consultant, Loxo Oncology: Grant/Research Support, Merck: Grant/Research Support, Merck: Advisor, Moderna: Consultant, Partner Therapeutics: Grant/Research Support, Relay Therapeutics: Grant/Research Support, Surface Oncology: Grant/Research Support, Tyra Biosciences: Grant/Research Support, Regeneron: Consultant, Tyra Biosciences: Consultant, Compass Therapeutics: Grant/Research Support, Compass Therapeutics: Consultant, Servier: Grant/Research Support 986 EFFICACY OF NITAZOXANIDE (NTZ) IN PATHOGEN-ASSOCIATED MOLECULAR PATTERNS (PAMPS)-INDUCED DISEASE MODELS Marie Bobowski-Gerard 1 Debaecker Simon 1 Philippe Delataille 1 Philippe POULAIN 1 Yacine Hajji 1 Sakina Sayah Jeanne 1 Dean Hum 1 David Dombrowicz 2 Vanessa Legry 1 Bart Staels 2 , 1 Genfit S.A., Loos, France, 2 INSERM U1011, Univ
La glucosamine est un lment constitutif essentiel des composs prsents dans le cartilage articulaire et un composant du collagne, qui donne de l'lasticit au tissu conjonctif des tendons
P2X7 Receptor: A Potential Therapeutic Target for Autoimmune Diseases
